| Financial Year |
March 31 2023 |
| Monetary Funds |
1,115,315,423.74 |
| Held-for-trading Financial Assets |
1,709,161,608.08 |
| Notes Receivable |
111,780,254.04 |
| Accounts Receivable |
859,896,462.76 |
| Advances to Suppliers |
141,121,518.54 |
| Other Receivables |
62,818,135.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
12,670,234.84 |
| Dividend Receivable |
-- |
| Inventories |
882,342,196.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
795,876,189.67 |
| Total Current Assets |
5,912,132,548.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
21,929,752,535.97 |
| Investment Properties |
24,668,725.73 |
| Fixed Assetes |
2,087,624,095.75 |
| Under-construction Projects |
180,009,923.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
7,208,198.49 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
367,539,434.58 |
| R&D expenses |
214,933,531.12 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,948,868.73 |
| Deferred Income Tax Assets |
286,657,564.98 |
| Other Non-Current Assets |
55,441,163.91 |
| Sub-Total of Non-Current Assets |
25,615,849,796.55 |
| Total Assets |
31,527,982,345.33 |
| Short-Term Loans |
700,945,060.24 |
| Trading Financial liabilities |
-- |
| Notes Payable |
11,760,876.56 |
| Accounts Payable |
400,584,382.68 |
| Accounts Received In Advance |
29,285,292.82 |
| Employee Compensation Payable |
76,464,247.71 |
| Taxes Payable |
43,853,853.03 |
| Interest Payable |
2,498,468.54 |
| Dividend Payable |
5,186.46 |
| Other payables |
728,930,425.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,347,208,407.58 |
| Other Current Liabilities |
2,651,134.33 |
| Sub-Total of Current Liabilities |
4,362,596,262.19 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,603,730.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
315,483,041.57 |
| Total Liabilities |
4,678,079,303.76 |
| Paid-In Capital(Or Share Stock) |
1,163,102,353.00 |
| Capital Surplus |
3,946,560,806.49 |
| Surplus Reserve |
2,350,346,323.89 |
| LESS:Treasury Stock |
570,069,754.45 |
| Undistributed Profits |
18,878,728,785.55 |
| Minority Stockholder's Interest |
308,224,829.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
26,541,678,212.19 |
| Owner's Equity（Stockholder's Equity） |
26,849,903,041.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
31,527,982,345.33 |
